Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Jasmina KapetanovicDr Jasmina Kapetanovic has been awarded an MRC Clinician Scientist Fellowship, for her research: 'New genetic therapy approaches for inherited retinal diseases.' The award will support her research on optimising the delivery and expression of genes in retinal disorders using latest technologies.

The focus of her research has been to use pre-clinical models to develop new treatments for inherited retinal degenerations, the commonest cause of blindness in working age population. One of the main obstacles in translating retinal genetic therapies is low efficiency of retinal vector transduction. To address this, the fellowship programme will develop innovative delivery strategies using robotic assistance to improve targeting of retinal neurons with gene therapy vectors. The project will also focus on optimising gene expression in mitochondria, for the treatment of optic neuropathies, and in inner retinal neurons for optogenetic applications to restore vision.

The MRC fellowship will allow her to establish her independent research programme within the Clinical Ophthalmology Research Group, and develop new treatments that can be applied directly to patients to prevent and restore sight loss.

Similar stories

New insights gained into how the brain encodes information about the world

Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Royal Academy of Engineering Research Fellowship

Dr Rezvan Farahibozorg has received one of 17 Royal Academy of Engineering Research Fellowships for 2022.

Three New Professors

Many congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.